Funding for Medical Research
and Clinical Trials
and Clinical Trials
Funding Details for Cancer
Use the contact information shown for the organization to apply for the funding.
Please notify CenTrial of any offer is incorrect or has expired.
Please notify CenTrial of any offer is incorrect or has expired.
ENDOMETRIAL/UTERINE CANCER
FOUNDATION FOR WOMEN’S CANCER
Type of Organization: Foundation
Email Address: research@sgo.org
Funds Available for Clinical Trials: ✗ Research: ✔
Other info: Recognizing that recurrence rates are higher and treatment options are more limited in aggressive subtypes of Endometrial Cancer, M. Regan's grant supports projects focusing on high-grade subtypes of uterine cancer (uterine serous cancer, clear cell, carcinosarcoma, poorly differentiated, and/or grade 3 endometrioid). Any area of research that would be expected to increase cure rates or prolong life is eligible, including new therapies, novel imaging, clinical trial adjuvant studies, molecular characterization, understating pathogenesis, etc. The Foundation gratefully acknowledges M. Regan for her support of this grant. This is the second grant supported by M. Regan.
Applications Open in August
FOUNDATION FOR WOMEN’S CANCER
Type of Organization: Foundation
Email Address: research@sgo.org
Funds Available for Clinical Trials: ✗ Research: ✔
Funding Details
Requirements:Other info: Recognizing that recurrence rates are higher and treatment options are more limited in aggressive subtypes of Endometrial Cancer, M. Regan's grant supports projects focusing on high-grade subtypes of uterine cancer (uterine serous cancer, clear cell, carcinosarcoma, poorly differentiated, and/or grade 3 endometrioid). Any area of research that would be expected to increase cure rates or prolong life is eligible, including new therapies, novel imaging, clinical trial adjuvant studies, molecular characterization, understating pathogenesis, etc. The Foundation gratefully acknowledges M. Regan for her support of this grant. This is the second grant supported by M. Regan.
Applications Open in August